Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2021

View Archived Issues

Medshine Discovery discovers ketohexokinase inhibitors

Dual GCGR and GLP-1 agonists patented by Merck & Co.

Bristol Myers Squibb patents diacylglycerol kinase alpha/zeta inhibitors

Evaluation of a mucosal vaccine based on recombinant N. lactamica expressing heterologous antigens

T-cell exhaustion is durable, but specific

Clinical trial of AP-003 in COVID-19 approved in Chile

FDA clears IND for lanraplenib in patients with AML

Discovery novel GPR119 agonist with excellent blood glucose-lowering effects

Ghent University Hybrid CAR-T cell platform has dual anti-HIV effects

FXa-DOAC reversal with no thrombogenic potential seen with VMX-C001

Boehringer Ingelheim advances development of alteplase for COVID-19 ARDS

Infinity reports data on eganelisib in combination therapy for urothelial cancer and TNBC

New phase II trial evaluates Orpathsys for advanced or metastatic MET-amplified gastric cancer

JadiCell reduces lung injury in animal model replicating COVID-19 Delta variant inflammation

First-in-human study investigates HJV inhibitor DISC-0974 for anemia of inflammation

Dosing underway in phase I trial of AR degrader GT-20029 in China

Mouse model shows targeting RagC GTPase could safely treat B-cell lymphomas

Ipsen and BAKX Therapeutics partner on BKX-001

University of Oxford tests vaccine against plague in phase I

Eccogene begins first-in-human study of ECC-0509 for NASH and osteoarthritis pain

DiosCURE enters licensing agreement for single-domain antibodies against SARS-CoV-2

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...